Fall 2004 Brown Bag Series
Tuesday,
September 28, 2004 -- Judith Andre, Ph.D.
The world grows ever smaller, and its burden of disease ever greater.
HIV, malaria, TB, and violence ravage much of the globe. Prof. Andre spent
last year in Toronto, a city often called the most cosmopolitan in the world.
Her research project concerned the ways in which our concepts of virtue need
to grow and change, particularly in the areas of health care and health policy,
but more broadly for everyone. What does compassion mean in a world so filled
with suffering? What does honesty mean when one is working in countries with
very different customs? Is hope possible? She will share her reflections on
what she learned from health professionals doing their work around the world.
At the end of this presentation participants will better appreciate the moral
challenges of international public health, recognize that bioethics concerns
moral ideals, not just "hard cases," and appreciate the importance
of public health.
Tuesday,
October 12, 2004 -- Margaret Holmes-Rovner, Ph.D.
Margaret Holmes-Rovner, Ph.D., is Professor of Health Services Research in the CHM Department of Medicine. Her research focuses on descriptive and prescriptive studies of patient and physician decision-making. Dr. Holmes-Rovner has developed decision aids and decision aid evaluation measures, participated in systematic reviews of decision aids, and conducted field studies of interactive video-based shared decision-making tools in hospital systems in Michigan. Her other on-going research is in health literacy, chronic disease management, and use of the electronic medical record to enhance patient participation in health care. She has served as President of the Society for Medical Decision Making, and a member, and later, Chair, of the Health Care Technology and Decision Sciences Study Section of the Agency for Healthcare Research and Quality, and Chair of the Centers for Disease Control Special Emphasis Panel on Patient Participation in Screening. She is also a founding member of the Shared Decision Making Forum-2000, funded by the Nuffield Trust to increase collaboration between North America and the United Kingdom (UK) in development, evaluation and implementation of shared decision-making.
Tuesday, November 9, 2004
-- Roundtable Discussion
Rodolfo Lopez, MD, (Bolivia) Psychiatrist, Cayetano Heredia University of Lima, Peru, Associate Professor in psychology at the University of San Adres, La Paz, Bolivia, National PRogramme Officer of United Nations Office on Drugs and Crime (ODCCP) La Paz, Postdoctoral fellow, Johns Hopkins University and Michigan State University, Department of Epidemiology.
Alejandro de la Torre, MD, (Colombia) Universidad del Valle in Cali, Colombia. Consultant for the mental health program, division of health promotion and protection of the Pan American Health Organization/World Health Organization (PAHO/WHO) in Washington, DC. Postdoctoral fellow, Johns Hopkins University and Michigan State University, Department of Epidemiology.
German Alvarado, MD, MPH (Peru), Cayetano Heredia Peruvian University. MPH at the Free University of Brussels, Belgium. Associate professor and Director of the MPH program at Cayetano Heredia Peruvian University (UPCH). Postdoctoral fellow, Johns Hopkins University and Michigan State University, Department of Epidemiology.
At the end of this presentation the participantswill be able to identify those issues encountered when applying US IRB rules in Latin American contexts, discuss how lessons learned from IRB work in developed countries might be applied in culturally sensitive ways in developing countries, and consider the ongoing need for a global community of science dialogue on how to best apply IRB rules in an international context.
Tuesday, November 30, 2004
-- Vernon K. Smith, Ph.D.
There needs to be at least five focal points for health care reform: Medicare, Medicaid, the Uninsured, cost control, and quality of care. But there are major political, economic and structural obstacles to achieving any of the needed reforms. The population covered by Medicare and Medicaid will continue to increase, especially after 2010. And the number of uninsured will likely grow as well by at least 20% over the next ten years. That by itself increases program costs. New medical technologies will also drive up costs and the burden of chronic illness will increase as more people live longer with more chronic illness. Two major things could be done to control health care costs: deep structural reform of the entire health care system (to achieve efficiencies needed to cover growing health needs) or greatly increased shifting of risks and costs of health care to individual consumers (employers forcing more co-pays on employees or requiring use of Medical Savings Accounts). There are almost insuperable political obstacles to both these ideas, and there are good moral reasons for resisting in particular any additional efforts to shift costs to consumers and patients. Muddling along with marginal adjustments here and there is not a sustainable strategy either, and could hardly be called "reform." What then should we do? What then should we hope for? What do we see as a genuine source of political will and political power to effect significant reform? At the end of this presentation the audience will be able to identify the four most important reasons why our health care system needs to be reformed, the major proposals for health reform and the major obstacles that would have to be overcome if any of these reform efforts were to be successful.
Vernon K. Smith, Ph.D., is a Principal with Health Management Associates, where he focuses on Medicade, SCHIP, state budgets and trends in the health care market place. He has authored several reports on the effects of the economic downturn of Medicaid, on enrollment trends in Medicaid and SCHIP, and on how states are responding to budget shortfalls. Dr. Smith has spoken on these issues before many national and state audiences, including the National Governors Associaton, the National Conference of State Legislatures, the Council of State Governments, the National Association of State Budget Officers, the National Association of State Medicaid Directors, the National Health Policy Forum, committees of the U.S. Congress, and Medicaid reform groups in several states. He has been a guest on National Public Radio and quoted on these issues in the New York Times, The Washington Post, The Wall Street Journal, Newsweek and USA Today. Before joining HMA, Dr. Smith served as Medicaid director and as budget director for the human services agency during his 30 years of public service in Michigan. He holds a Ph.D. in economics from Michigan State University.
Thursday, December 2, 2004
-- Declan O'Reilly, Ph.D.
Medical
organization in 18th century Colonial America followed English practice, but
there were a number of important differences. The profession in England was
self consciously elitist, but in the United States no such stratification
was possible, in part because of the general paucity of doctors, but also
because of America’s burgeoning democratic ideal, which militated against
any attempt to create a more socially exclusive profession. However, it is
reasonable to argue that by 1850 the profession had achieved a new level of
authority, which supported a professionalizing ethos. American medicine was
proving itself to be forward looking and scientific, both essential attributes
for the transition from traditional holistic theories to medicine to the more
heroic style of the later 19th century. It was a transition that would radically
alter the structure and ethos of modern American medicine. Participants
will gain an appreciation for the historical influences shaping the US profession
of medicine.
Dr.
O'Reilly was educated at the Universities of London and Cambridge and has
taught at Queen Mary College, London, and at Middlesex University as well
as for the MSU London Study Abroad Program “Medical Ethics and History
of Health Care”. He was Senior Research Associate and Fellow of the
Wellcome Trust Centre for the History of Medicine at University College London
working on the new history of Burroughs Wellcome Company (1880-1940) and is
now the Charles C. Price Fellow at the Beckman Centre for Chemical History
in Philadelphia. His interests range from technology transfer between Germany
and Britain to the history of the chemical and pharmaceutical industry.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Michigan State University, College of Human Medicine and the Center for Ethics and Humanities in the Life Sciences. The Michigan State University College of Human Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Michigan State University College of Human Medicine, designates this educational activity for a maximum of 1 hour in category 1 credit per session towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.
